Group 1: Company Overview - Daxor Corporation is the global leader in blood volume measurement technology, focusing on blood volume testing innovation [4] - The company developed the BVA-100® (Blood Volume Analyzer), the only FDA-cleared diagnostic blood test for quantifying blood volume status and composition [4] - Over 65,000 tests have been performed at leading hospital centers across the U.S., significantly reducing mortality and readmissions in heart failure and critical care [4] Group 2: Technology Impact - Daxor's blood volume analysis (BVA) has shown a significant impact on patient outcomes, altering fluid and red blood cell interventions in 44% of cases and reducing mortality by 66% in surgical intensive care units [2] - The technology also contributes to decreased hospital stays and ventilator days, enhancing healthcare economics [2] Group 3: Industry Context - The Society for Critical Care Medicine (SCCM) is the largest nonprofit medical organization dedicated to promoting excellence in critical care, with members in over eighty countries [3] - The SCCM 2025 Critical Care Congress will provide a strategic platform for Daxor to showcase its innovative solutions [2][3]
Daxor to Exhibit at World's Largest Critical Care Conference